In almost all of the reviewed publications, PVT1 upregulation correlates with a shorter survival in RCC patients, even though some exceptions need to be highlighted [102] where PVT1 was not among the most prominent candidates. The gene discussed is PVT1; the disease is renal cell carcinoma.